  |
Dr. Jeff Colyer, the former governor of Kansas who is a practicing physician, reported Sunday in the Wall Street Journal that the combination of hydroxychloroquine and azithromycin is continuing to show “promising” results in coronavirus patients.
read more at http://www.informationliberation.com/?id=61333
President Donald Trump’s excitement about decades-old anti-malarial drugs to treat the coronavirus has touched off widespread interest in the medications, hoarding by some doctors, new clinical trials on the fly and desperation among patients who take them for other conditions.
Many experts say there isn’t enough evidence that the drugs work for the coronavirus, but at least a few say there’s little to lose in giving hydroxychloroquine to patients who are severely ill with coronavirus.
“It’s unlikely to worsen COVID-19, and given that it might help … we have literally nothing else to offer these patients other than supportive care,” said Dr. David Juurlink, an internist and head of the division of clinical pharmacology and toxicology at the University of Toronto in Canada.
Here’s what we know and don’t know about the drugs, chloroquine and hydroxychloroquine, also known by the brand name Plaquenil.
additional information on topic here (via Ryan Underwood): https://www.propublica.org/article/what-we-know-and-dont-know-about-possible-coronavirus-treatments-promoted-by-trump
summary via R3publicans: https://r3publican.wordpress.com
R3publicans 